Publisher： John Wiley & Sons Inc
E-ISSN： 2050-0904|3|6|472-478
ISSN： 2050-0904
Source： Clinical Case Reports, Vol.3, Iss.6, 2015-06, pp. : 472-478
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Rodriguez L Mardrus P Grand JL Le Molenat F Reboul M Garrigues B
Clinical Intensive Care, Vol. 12, Iss. 4, 2001-08 ,pp. :
Access to resources
Recommend
Thalidomide in Cutaneous Lupus Erythematosus
American Journal of Clinical Dermatology, Vol. 4, Iss. 6, 2003-01 ,pp. :
By Powell R.J.
BioDrugs, Vol. 11, Iss. 6, 1999-06 ,pp. :
Theoretical Basis for the Activity of Thalidomide
By Meierhofer C. Dunzendorfer S. Wiedermann C.J.
BioDrugs, Vol. 15, Iss. 10, 2001-10 ,pp. :